Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 5;24(6):e00004-17.
doi: 10.1128/CVI.00004-17. Print 2017 Jun.

Pneumococcal Capsular Polysaccharide Immunity in the Elderly

Affiliations
Review

Pneumococcal Capsular Polysaccharide Immunity in the Elderly

Hugh Adler et al. Clin Vaccine Immunol. .

Abstract

Immunity to pneumococcal infections is impaired in older people, and current vaccines are poorly protective against pneumococcal disease in this population. Naturally acquired immunity to pneumococcal capsular polysaccharides develops during childhood and is robust in young adults but deteriorates with advanced age. In particular, antibody levels and function are reduced in older people. Pneumococcal vaccines are recommended for people >65 years old. However, the benefits of polysaccharide and protein-conjugated vaccines in this population are small, because of both serotype replacement and incomplete protection against vaccine serotype pneumococcal disease. In this review, we overview the immune mechanisms by which naturally acquired and vaccine-induced pneumococcal capsular polysaccharide immunity declines with age, including altered colonization dynamics, reduced opsonic activity of antibodies (particularly IgM), and impaired mucosal immunity.

Keywords: Streptococcus pneumoniae; aging; colonization; immunization; immunoglobulins; mucosal immunity; pneumococcus; pneumonia.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Anticapsular antibodies can be acquired naturally (following pneumococcal exposure, e.g., colonization, or through pneumococcal disease) or via vaccination. They facilitate pneumococcal killing via opsonization. In addition, they can prevent the development of colonization in the future—this has been shown to be mediated via agglutination in the case of antibodies induced by protein-conjugated pneumococcal vaccines.
FIG 2
FIG 2
Schematic of pneumococcal disease rates, pneumococcal colonization rates, and pneumococcal antibody activity in different age groups. Pneumococcal colonization and disease rates are high in young children. Naturally acquired pneumococcal anti-CPS antibody levels rise with recurrent exposure. Young adults have high levels of naturally acquired antibodies, occasional episodes of colonization, and low rates of disease. In the elderly, antibody levels are low and functional activity is even lower, colonization is infrequent, and rates of pneumococcal disease increase.
None
None
None
None

References

    1. Welte T, Torres A, Nathwani D. 2012. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 67:71–79. doi:10.1136/thx.2009.129502. - DOI - PubMed
    1. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, Chappell JD, Qi C, Hart EM, Carroll F, Trabue C, Donnelly HK, Williams DJ, Zhu Y, Arnold SR, Ampofo K, Waterer GW, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, McCullers JA, Pavia AT, Edwards KM, Finelli L. 2015. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373:415–427. doi:10.1056/NEJMoa1500245. - DOI - PMC - PubMed
    1. Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, Zell ER, Linder JA, Grijalva CG, Metlay JP, Finkelstein JA. 2011. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 29:3398–3412. doi:10.1016/j.vaccine.2011.02.088. - DOI - PubMed
    1. Wroe PC, Finkelstein JA, Ray GT, Linder JA, Johnson KM, Rifas-Shiman S, Moore MR, Huang SS. 2012. Aging population and future burden of pneumococcal pneumonia in the United States. J Infect Dis 205:1589–1592. doi:10.1093/infdis/jis240. - DOI - PubMed
    1. Bijlsma MW, Brouwer MC, Kasanmoentalib ES, Kloek AT, Lucas MJ, Tanck MW, van der Ende A, van de Beek D. 2016. Community-acquired bacterial meningitis in adults in the Netherlands, 2006–14: a prospective cohort study. Lancet Infect Dis 16:339–347. doi:10.1016/S1473-3099(15)00430-2. - DOI - PubMed

LinkOut - more resources